SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Revenue for the quarter ended  September 2022 of Rs. 6248.30 millions grew by 22.35 % from Rs. 5107.00 millions.Net profit declined -9.92% to Rs. 365.80 millions from Rs. 406.10 millions.The company reported a good operating profit of 702.70 millions compared to 700.20 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 6248.30 5107.00 22.35 11760.30 10164.90 15.70 22511.70 19148.90 17.56
Other Income 0.90 8.90 -89.89 3.30 25.30 -86.96 47.80 64.20 -25.55
PBIDT 702.70 700.20 0.36 1252.40 1459.30 -14.18 3229.50 4077.00 -20.79
Interest 82.70 51.10 61.84 150.60 92.20 63.34 200.60 226.10 -11.28
PBDT 620.00 649.10 -4.48 1101.80 1367.10 -19.41 3028.90 3853.10 -21.39
Depreciation 119.20 118.00 1.02 237.50 235.60 0.81 473.90 476.00 -0.44
PBT 500.80 531.10 -5.71 864.30 1131.50 -23.61 2555.00 3377.10 -24.34
TAX 135.00 125.00 8.00 235.00 270.00 -12.96 605.00 800.00 -24.38
Deferred Tax 5.00 -5.00 -200.00 15.00 -10.00 -250.00 -50.00 -45.00 11.11
PAT 365.80 406.10 -9.92 629.30 861.50 -26.95 1950.00 2577.10 -24.33
Equity 926.00 926.00 0.00 926.00 926.00 0.00 926.00 932.00 -0.64
PBIDTM(%) 11.25 13.71 -17.97 10.65 14.36 -25.82 14.35 21.29 -32.62

Aarti Drugs Share Price

370.75 0.50 (0.14%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: